Literature DB >> 18285351

Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.

Ling Zheng1, Raja Sinniah, Stephen I-Hong Hsu.   

Abstract

In vitro and in vivo experimental studies suggest that the transcription factor NF-kappaB plays a role in tubulointerstitial injury. We investigated possible cellular and molecular mechanisms involving NF-kappaB activation in the progression of tubulointerstitial lesions in human lupus nephritis (LN). Paraffin-embedded renal biopsies from 50 patients with LN and six control patients with minimal change disease (MCD) were examined by Southwestern histochemistry for in situ detection of active NF-kappaB and AP-1. Immunohistochemistry was performed to examine the expression of NF-kappaB, AP-1, and NF-kappaB regulatory proteins (IkappaB-alpha, p-IkappaB-alpha, and IKK-alpha proteins), as well as NF-kappaB and AP-1 downstream target proinflammatory molecules (ICAM-1, TNF-alpha, IL-1beta, IL-6, and GM-CSF) and NF-kappaB upstream signaling molecules (CD40 and CD40L). We observed extensive upregulation of activated NF-kappaB in renal tubular cells and interstitial cells, in parallel with overactivation of transcription factor AP-1 in LN, as compared with normal controls and MCD. Tubular expression of activated NF-kappaB correlated well with the degree of tubulointerstitial histopathological indices and/or renal function. Tubulointerstitial IKK-alpha expression was specifically upregulated in LN. IkappaB-alpha and p-IkappaB-alpha were detected only in interstitial cells in LN. Tubulointerstitial expression levels of NF-kappaB and AP-1 downstream inflammatory molecules and NF-kappaB upstream signaling molecules CD40 and CD40L were markedly enhanced in LN as compared with MCD or normal controls and were associated with tubulointerstitial histopathological indices and/or renal function. The results suggest that altered IKK-alpha expression and NF-kappaB activation along with AP-1 overexpression may play a pathogenic role in tubulointerstitial injury in human LN mediated through a network of downstream proinflammatory molecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285351      PMCID: PMC2324188          DOI: 10.1369/jhc.7A7368.2008

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  55 in total

1.  Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction.

Authors:  J J Morrissey; S Klahr
Journal:  Kidney Int       Date:  1997-10       Impact factor: 10.612

Review 2.  Transcription factors as activators of gene transcription: AP-1 and NF-kappa B.

Authors:  I M Adcock
Journal:  Monaldi Arch Chest Dis       Date:  1997-04

3.  Dysregulation of cytokine expression in tubulointerstitial nephritis associated with murine malaria.

Authors:  L Rui-Mei; A U Kara; R Sinniah
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

4.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 5.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

6.  ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.

Authors:  R S Thomas; M J Tymms; L H McKinlay; M F Shannon; A Seth; I Kola
Journal:  Oncogene       Date:  1997-06-12       Impact factor: 9.867

7.  Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody.

Authors:  C Kaltschmidt; B Kaltschmidt; T Henkel; H Stockinger; P A Baeuerle
Journal:  Biol Chem Hoppe Seyler       Date:  1995-01

Review 8.  Adhesion molecules in renal disease.

Authors:  A Dal Canton
Journal:  Kidney Int       Date:  1995-12       Impact factor: 10.612

9.  Macrophage growth factors introduced into the kidney initiate renal injury.

Authors:  T Naito; H Yokoyama; K J Moore; G Dranoff; R C Mulligan; V R Kelley
Journal:  Mol Med       Date:  1996-05       Impact factor: 6.354

10.  Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.

Authors:  Y Hsing; B S Hostager; G A Bishop
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

View more
  26 in total

1.  Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.

Authors:  Zeming Zhang; Dongmei Liu; Xiaoli Zhang; Xiaofei Wang
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis.

Authors:  Xue Zhao; Jun Hao; Huijun Duan; Zanhua Rong; Fan Li
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

3.  NF-kB signaling in myeloid cells mediates the pathogenesis of immune-mediated nephritis.

Authors:  Samantha A Chalmers; Sayra J Garcia; Joshua A Reynolds; Leal Herlitz; Chaim Putterman
Journal:  J Autoimmun       Date:  2019-01-03       Impact factor: 7.094

4.  ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation.

Authors:  Erik A Korte; Dawn J Caster; Michelle T Barati; Min Tan; Shirong Zheng; Celine C Berthier; Frank C Brosius; Mark B Vieyra; Ryan M Sheehan; Michele Kosiewicz; Marcin Wysoczynski; Patrick M Gaffney; David J Salant; Kenneth R McLeish; David W Powell
Journal:  Am J Pathol       Date:  2017-09-19       Impact factor: 4.307

5.  A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice.

Authors:  Min Li; Xiaowei Shi; Tian Qian; Jian Li; Zhiqiang Tian; Bing Ni; Fei Hao
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Exacerbating lupus nephritis following BPA exposure is associated with abnormal autophagy in MRL/lpr mice.

Authors:  Youdan Dong; Zeming Zhang; Hezuo Liu; Lihong Jia; Muting Qin; Xiaofei Wang
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

7.  Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure.

Authors:  Yanrong Zhang; Santiago Cuevas; Laureano D Asico; Crisanto Escano; Yu Yang; Annabelle M Pascua; Xiaoyan Wang; John E Jones; David Grandy; Gilbert Eisner; Pedro A Jose; Ines Armando
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

8.  Chronic Kidney Disease is associated with an increase of Intimal Dendritic cells in a comparative autopsy study.

Authors:  Estanis Navarro; Josep Grinyó; Miguel Hueso; Joan Torras; Marta Carrera; August Vidal
Journal:  J Inflamm (Lond)       Date:  2015-03-29       Impact factor: 4.981

9.  Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.

Authors:  Qiongyi Hu; Chunxin Yang; Qiang Wang; Haiying Zeng; Wanzhang Qin
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

10.  ABIN1 dysfunction as a genetic basis for lupus nephritis.

Authors:  Dawn J Caster; Erik A Korte; Sambit K Nanda; Kenneth R McLeish; Rebecca K Oliver; Rachel T G'sell; Ryan M Sheehan; Darrell W Freeman; Susan C Coventry; Jennifer A Kelly; Joel M Guthridge; Judith A James; Kathy L Sivils; Marta E Alarcon-Riquelme; R Hal Scofield; Indra Adrianto; Patrick M Gaffney; Anne M Stevens; Barry I Freedman; Carl D Langefeld; Betty P Tsao; Bernardo A Pons-Estel; Chaim O Jacob; Diane L Kamen; Gary S Gilkeson; Elizabeth E Brown; Graciela S Alarcon; Jeffrey C Edberg; Robert P Kimberly; Javier Martin; Joan T Merrill; John B Harley; Kenneth M Kaufman; John D Reveille; Juan-Manuel Anaya; Lindsey A Criswell; Luis M Vila; Michelle Petri; Rosalind Ramsey-Goldman; Sang-Cheol Bae; Susan A Boackle; Timothy J Vyse; Timothy B Niewold; Philip Cohen; David W Powell
Journal:  J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.